NIBRT is looking to procure an instrument for cell therapy development applications. The desired platform is one that supports the rapid development of assays using single cells to enable exploration of cell therapy features, including but not limited to, screening of chimeric antigen receptor T cell constructs, discovery of T cell receptors or antigens, or exploration of regulatory T cell functions. The instrumental capabilities will be used by NIBRT as part of their current expansion and diversification to support all aspects of advanced therapy development and manufacture. The proposed instrument will be used to further our understanding of T cell immunotherapies through exploration of their phenotype, function and genotype.
Deadline
The time limit for receipt of tenders was 2022-06-27.
The procurement was published on 2022-05-27.
Suppliers
The following suppliers are mentioned in award decisions or other procurement documents:
Object Scope of the procurement
Title: A single cell platform for T-Cell therapy development
PR22-013
Products/services: Laboratory, optical and precision equipments (excl. glasses)📦
Short description:
“NIBRT is looking to procure an instrument for cell therapy development applications. The desired platform is one that supports the rapid development of...”
Short description
NIBRT is looking to procure an instrument for cell therapy development applications. The desired platform is one that supports the rapid development of assays using single cells to enable exploration of cell therapy features, including but not limited to, screening of chimeric antigen receptor T cell constructs, discovery of T cell receptors or antigens, or exploration of regulatory T cell functions. The instrumental capabilities will be used by NIBRT as part of their current expansion and diversification to support all aspects of advanced therapy development and manufacture. The proposed instrument will be used to further our understanding of T cell immunotherapies through exploration of their phenotype, function and genotype.
Show more
Estimated value excluding VAT: EUR 650 000 💰
1️⃣
Additional products/services: Laboratory, optical and precision equipments (excl. glasses)📦
Place of performance: Dublin🏙️
Main site or place of performance:
“National Institute For Bioprocessing Research and Training (NIBRT), Fosters Avenue, Mount Merrion, Blackrock, Co. Dublin”
Description of the procurement:
“NIBRT is looking to procure an instrument for cell therapy development applications. The desired platform is one that supports the rapid development of...”
Description of the procurement
NIBRT is looking to procure an instrument for cell therapy development applications. The desired platform is one that supports the rapid development of assays using single cells to enable exploration of cell therapy features, including but not limited to, screening of chimeric antigen receptor T cell constructs, discovery of T cell receptors or antigens, or exploration of regulatory T cell functions. The instrumental capabilities will be used by NIBRT as part of their current expansion and diversification to support all aspects of advanced therapy development and manufacture. The proposed instrument will be used to further our understanding of T cell immunotherapies through exploration of their phenotype, function and genotype.
Show more Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
Scope of the procurement
Estimated total value excluding VAT: EUR 650 000 💰
Duration of the contract, framework agreement or dynamic purchasing system
The time frame below is expressed in number of months.
Description
Duration: 12
Legal, economic, financial and technical information Economic and financial standing
Selection criteria as stated in the procurement documents
Technical and professional ability
Selection criteria as stated in the procurement documents
Procedure Type of procedure
Open procedure
Administrative information
Time limit for receipt of tenders or requests to participate: 2022-06-27
17:00 📅
Languages in which tenders or requests to participate may be submitted: English 🗣️
Conditions for opening of tenders: 2022-06-27
17:00 📅
Complementary information Review body
Name: Nibrt
Postal address: Fosters Avenue
Postal town: Dublin
Postal code: A94 X099
Country: Ireland 🇮🇪
E-mail: karl.kelly@nibrt.ie📧
Source: OJS 2022/S 105-292961 (2022-05-27)
Contract award notice (2022-10-17) Object Scope of the procurement
Total value of the procurement (excluding VAT): EUR 481 121 💰
Award criteria
Quality criterion (name): Product Quality and Fitness for Purpose
Quality criterion (weighting): 40
Quality criterion (name): Training Services
Quality criterion (weighting): 20
Quality criterion (name): Warranty Services
Quality criterion (weighting): 10
Quality criterion (name): Technical Support and Maintenance Services
Quality criterion (weighting): 15
Price (weighting): 15
Procedure Administrative information
Previous publication concerning this procedure: 2022/S 105-292961
Award of contract
1️⃣
Contract Number: 1
Title: A single cell platform for T-Cell therapy development
Date of conclusion of the contract: 2022-06-30 📅
Information about tenders
Number of tenders received: 1
Number of tenders received by electronic means: 1
Name and address of the contractor
Name: Berkeley Lights
National registration number: 377130692
Postal address: 5858 Horton Street. Suite 320
Postal town: Emeryville
Postal code: California
Country: United States 🇺🇸
Phone: +44 7377130212📞
E-mail: matthew.dunne@berkeleylights.com📧
Region: us 🏙️
The contractor is an SME
Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot: EUR 481 121 💰
Source: OJS 2022/S 204-578834 (2022-10-17)